Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: Results from Southwest Oncology Group randomized trials

Primo N. Lara, Mary W. Redman, Karen Kelly, Martin J. Edelman, Stephen K. Williamson, John J. Crowley, David R. Gandara

Research output: Contribution to journalArticlepeer-review

165 Scopus citations

Fingerprint

Dive into the research topics of 'Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: Results from Southwest Oncology Group randomized trials'. Together they form a unique fingerprint.

Nursing and Health Professions

Medicine and Dentistry

Mathematics

Pharmacology, Toxicology and Pharmaceutical Science